Citeline Podcasts

On this week's podcast, we discussed cybersecurity, colorectal cancer screening guidelines, tax and patent legal rulings, and a busy week from FDA with rules and guidance documents.

On this week's podcast, we discussed a new insomnia device, congressional action, campaign contributions, FDA and private insurers, patient's getting their device data, and our recent interview with AdvaMed CEO Scott Whitaker.

On this week's podcast, we discussed a new insomnia device, congressional action, campaign contributions, FDA and private insurers, patient's getting their device data, and our recent interview with AdvaMed CEO Scott Whitaker.

On this week's podcast, we discussed a new insomnia device, congressional action, campaign contributions, FDA and private insurers, patient's getting their device data, and our recent interview with AdvaMed CEO Scott Whitaker.

On this week's podcast, we discuss details we have learned on the recently announced agreement for new European Union device and diagnostic regulations and the next steps towards adoption.

On this week's podcast, we discuss details we have learned on the recently announced agreement for new European Union device and diagnostic regulations and the next steps towards adoption.

On this week's podcast, we discuss details we have learned on the recently announced agreement for new European Union device and diagnostic regulations and the next steps towards adoption.

While ransomware attacks in the medical industry have so far been limited to hospital providers, RES’ Ellen Derrico says it's not a matter of if but when such attacks start targeting medical devices and manufacturers need to be prepared.

While ransomware attacks in the medical industry have so far been limited to hospital providers, RES’ Ellen Derrico says it's not a matter of if but when such attacks start targeting medical devices and manufacturers need to be prepared.

While ransomware attacks in the medical industry have so far been limited to hospital providers, RES’ Ellen Derrico says it's not a matter of if but when such attacks start targeting medical devices and manufacturers need to be prepared.